| Combination of | |
|---|---|
| Oxytocin | Hypothalamic hormone |
| Ergometrine | Ergot alkaloid |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Intramuscular injection |
| Identifiers | |
| CAS number | 37209-62-4 |
| ATC code | ? |
| PubChem | CID 11979741 |
| |
|
Oxytocin/ergometrine (trade name Syntometrine) is an obstetric combination drug. The components are synthetically produced oxytocin, a human hormone produced in the hypothalamus, and ergometrine, an alpha-adrenergic, dopaminergic and serotonin (5-HT2) receptor agonist.
Both substances cause the uterus to contract. An injection of syntometrine is given in the third stage of labor, just after the birth of the child, to facilitate delivery of the placenta[1] and to prevent postpartum hemorrhage[1] by causing smooth muscle tissue in the blood vessel walls to narrow, thereby reducing blood flow.
|
Contents
|
Syntometrine should not be used in:
It should be used with caution in:
Possible side effects include:
A heath care provider should immediately be noticed by the patient when experiencing any side effects. They may be signs of allergy or of too much fluid associated with high doses or long infusions.[2]
Prostaglandins increase the effect of oxytocin and vice-versa. The contractions should be carefully monitored if oxytocin is given after a prostaglandin dose.
Syntometrine may enhance the blood pressure raising effect of vasoconstrictors (medicines given to constrict the blood vessels).
Some inhaled anaesthetics used for general anaesthesia, such as cyclopropane and halothane, may reduce the effect of oxytocin and ergometrine. There may also be an increased risk of a drop in blood pressure and abnormal heart beats if oxytocin is given with these general anaesthetics.
|
|||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)